Index stratifies risk for advanced colorectal neoplasia

August 12, 2015

Index stratifies risk for advanced colorectal neoplasia
(HealthDay)—A scoring system can stratify risk for advanced colorectal neoplasia in asymptomatic adults, according to a study published online Aug. 11 in the Annals of Internal Medicine.

Thomas F. Imperiale, M.D., from the Indiana University School of Medicine in Indianapolis, and colleagues conducted a cross-sectional study to create a risk index for advanced neoplasia anywhere in the colorectum, using the most common risk factors for . Data were included for persons aged 50 to 80 years undergoing initial screening colonoscopy.

The researchers found that the prevalence of advanced neoplasia was 9.4 percent among 2,993 persons in the derivation set. For people classified as being at very low, low, intermediate, and high risk, the risks for advanced neoplasia were 1.92, 4.88, 9.93, and 24.9 percent, respectively (P < 0.001). In the low-risk groups, sigmoidoscopy to the descending colon would have detected 73 percent of advanced neoplasms. The corresponding risks for advanced neoplasia were 1.65, 3.31, 10.9, and 22.3 percent, respectively, among the 1,467 persons in the validation set (P < 0.001). Sigmoidoscopy would have detected 87.5 percent of advanced neoplasms.

"The score may be useful in counseling average-risk patients about their risk for ," writes the author of an accompanying editorial. "But until stronger scientific evidence is available, I would not recommend such scores for choosing the type of screening test an average-risk person should have."

Explore further: Factors ID'd for CRC risk stratification with positive FIT

More information: Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Factors ID'd for CRC risk stratification with positive FIT

September 12, 2014
(HealthDay)—Fecal hemoglobin concentration, sex, and age can be used to classify the risk of advanced colorectal neoplasia among individuals with positive results from fecal immunochemical tests (FITs), according to a study ...

'Scoring system' may spot those in greatest need of colonoscopy

August 11, 2015
(HealthDay)— Colonoscopy can save lives, but experts agree that testing rates remain too low. Now, researchers say a special scoring system might point to those people at highest risk for colon cancer, who may need the ...

Review: weak power in most CRC neoplasia risk prediction models

October 14, 2014
(HealthDay)—Most colorectal neoplasia risk prediction models have weak discriminatory power, according to a review published in the October issue of Clinical Gastroenterology and Hepatology.

Support for fecal testing in familial colorectal cancer screening

October 29, 2014
Fecal immunochemical tests (FIT) may be as effective as colonoscopies when it comes to detecting colorectal cancer among first-degree relatives of patients with colorectal cancer, according to a new study in Gastroenterology, ...

Recommended for you

A molecule for fighting muscular paralysis

November 19, 2018
Myotubular myopathy is a severe genetic disease that leads to muscle paralysis from birth and results in death before two years of age. Although no treatment currently exists, researchers from the University of Geneva (UNIGE), ...

New drug discovery could halt spread of brain cancer

November 19, 2018
The tissues in our bodies largely are made of fluid. It moves around cells and is essential to normal body function.

Scientists trained a computer to classify breast cancer tumors

November 19, 2018
Using technology similar to the type that powers facial and speech recognition on a smartphone, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have trained a computer to analyze breast ...

New dual-action cancer-killing virus

November 19, 2018
Scientists have equipped a virus that kills carcinoma cells with a protein so it can also target and kill adjacent cells that are tricked into shielding the cancer from the immune system.

Use genetic data to predict the best time of day to give radiotherapy to breast cancer patients, say researchers

November 19, 2018
A new clinical study led by the University of Leicester and conducted in the HOPE clinical trials facility at Leicester's Hospitals has revealed the pivotal role that changing the time of day that a patient receives radiotherapy ...

New blood test detects early stage ovarian cancer

November 19, 2018
Research on a bacterial toxin first discovered in Adelaide has led to the development a new blood test for the early diagnosis of ovarian cancer—a disease which kills over 1000 Australian women and 150,000 globally each ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.